The estimated Net Worth of Sean Ellis is at least $182 Thousand dollars as of 21 August 2023. Mr. Ellis owns over 40,000 units of Entera Bio Ltd stock worth over $181,738 and over the last 3 years he sold ENTX stock worth over $0. In addition, he makes $0 as Director at Entera Bio Ltd.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Sign up
Mr. Ellis ENTX stock SEC Form 4 insiders trading
Sean has made over 4 trades of the Entera Bio Ltd stock since 2022, according to the Form 4 filled with the SEC. Most recently he bought 40,000 units of ENTX stock worth $24,000 on 21 August 2023.
The largest trade he's ever made was buying 40,000 units of Entera Bio Ltd stock on 21 August 2023 worth over $24,000. On average, Sean trades about 11,863 units every 72 days since 2022. As of 21 August 2023 he still owns at least 102,100 units of Entera Bio Ltd stock.
You can see the complete history of Mr. Ellis stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Sean Ellis biography
Sean Ellis serves as Director of the Company. Mr. Ellis brings extensive knowledge of both life science industries and the U.S. financial markets, with a longstanding history in asset management. Mr. Ellis is a fund manager of Centillion Fund, a venture capital fund dedicated to Israeli investments, with a primary focus on investments in the biotech and healthcare industries. Centillion is one of Entera Bio’s earliest investors and largest shareholders. Mr. Ellis is also the Managing Partner and founder of Redstone Capital, a technology venture capital fund operating in Eastern Europe and funded by SBI Japan and others. He holds a BA from New York University and MBA from Columbia University.
How old is Sean Ellis?
Sean Ellis is 45, he's been the Director of Entera Bio Ltd since 2019. There are 13 older and 5 younger executives at Entera Bio Ltd. The oldest executive at Entera Bio Ltd is Gerald Lieberman, 73, who is the Independent Chairman of the Board.
What's Sean Ellis's mailing address?
Sean's mailing address filed with the SEC is KIRYAT HADASSAH, MINRAV BUILDING, FIFTH FLOOR, JERUSALEM, L3, 9112002.
Insiders trading at Entera Bio Ltd
Over the last 3 years, insiders at Entera Bio Ltd have traded over $0 worth of Entera Bio Ltd stock and bought 467,822 units worth $484,536 . The most active insiders traders include Gerald M Lieberman, Miranda Jayne Toledano, and Sean Ellis. On average, Entera Bio Ltd executives and independent directors trade stock every 32 days with the average trade being worth of $36,205. The most recent stock trade was executed by Haya Taitel on 12 January 2024, trading 9,500 units of ENTX stock currently worth $9,405.
What does Entera Bio Ltd's logo look like?
Complete history of Mr. Ellis stock trades at Entera Bio Ltd
Entera Bio Ltd executives and stock owners
Entera Bio Ltd executives and other stock owners filed with the SEC include:
-
Phillip Schwartz,
President of Research and Development -
Gerald Lieberman,
Independent Chairman of the Board -
Arthur Santora,
Chief Medical Officer -
Dr. Phillip Schwartz Ph.D.,
Exec. VP, Pres of R&D and Director -
Roger Garceau,
Chief Executive Officer, Director -
Hillel Galitzer,
Chief Operating Officer -
Dr. Hillel Galitzer,
Chief Operating Officer -
Dr. Arthur C. Santora II, M.D., Ph.D.,
Chief Medical Officer -
Kiryat Hadassah,
IR Contact Officer -
Miranda Toledano,
Independent Director -
Gerald Ostrov,
Independent Director -
Faith Charles,
Independent Director -
Yonatan Malca,
Director -
Sean Ellis,
Director -
Zeev Bronfeld,
Director -
Jonathan Lieber,
Chief Financial Officer - U.S.-based -
Dana Yaacov-Garbeli,
Chief Financial Officer -
Dr. Roger J. Garceau,
Chief Devel. Advisor & Director -
Ramesh Ratan,
U.S. Chief Financial Officer -
Dana Yaacov-Garbeli CPA,
Chief Financial Officer -
Dr. Spiros Jamas,
CEO & Director -
Haya Taitel,
Director -
Ramesh Ratan,
U.S.based CFO -
Spiros Jamas,
Chief Executive Officer -
Ron Mayron,
Director